Example: Heart Attack

Clinical Trials on Borderline Resectable Adenocarcinoma of the Head of the Pancrease

Total 9779 results

NCT04832399

Completed

Study of Tysabri in Early Relapsing Remitting Multiple Sclerosis Participants (TYPIFI)

Relapsing Remitting Multiple Sclerosis
NCT04261556

Withdrawn

tDCS to Enhance Cognitive Training in Multiple Sclerosis (REHACOG-MS)

Multiple Sclerosis, Relapsing-Remitting
NCT06039007

Active, not recruiting

A run-in Study on the Safety and Tolerability of a Fasting Mimicking Diet in Relapsing Remitting Multiple Sclerosis (FAST-MS)

Multiple Sclerosis
NCT04233970

Completed

Development and Evaluation of a Web-based Programme on Relapse Management for People With Multiple Sclerosis (POWER@MS2)

Multiple Sclerosis, Relapsing-Remitting
NCT05950308

Completed

Assessment of Immune Response in Multiple Sclerosis Patients With COVID-19/Vaccination Treated With Ofatumumab and Other Disease Modifying Therapies

Multiple Sclerosis
NCT04711148

Active, not recruiting

A Phase 2 Study of Orelabrutinib in Patients With Relapsing-Remitting Multiple Sclerosis

Relapsing Remitting Multiple Sclerosis
NCT05104762

Completed

IVIG Versus Plasmapheresis in the Treatment of Guillian Barrie Syndrome Patients

Guillain-Barre Syndrome
NCT04767698

Terminated

Addition of Belimumab to B-cell Depletion in Relapsing-remitting Multiple Sclerosis

Multiple Sclerosis
NCT03464448

Completed

Mechanistic Studies of Teriflunomide in RRMS

Relapsing Remitting Multiple Sclerosis
NCT03381170

Completed

An Extension of the TG1101-RMS201 Trial

Relapsing Remitting Multiple Sclerosis
NCT05604092

Completed

Lesion Load and Location in Relation to Cognition, Fatigue and Physical Disability in RRMS

Relapsing Remitting Multiple Sclerosis
NCT05351411

Completed

Exercise on Contactin-1 and Contactin-2 Level in Persons With Multiple Sclerosis

Relapsing Remitting Multiple Sclerosis
NCT02255656

Completed

Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409 (TOPAZ)

Relapsing Remitting Multiple Sclerosis
NCT02873819

Completed

Safety and Efficacy Study of GL-0817 (With Cyclophosphamide) for the Prevention of Recurrence of Squamous Cell Carcinoma of the Oral Cavity

Squamous Cell Carcinoma of the Oral Cavity
NCT03157830

Completed

Evaluating the Efficacy and Safety of Transitioning Patients From Natalizumab to Ocrelizumab (OCTAVE)

Relapsing Remitting Multiple Sclerosis
NCT04925778

Withdrawn

Observational Study in Patients With Relapsing-Remitting Multiple Sclerosis Switched to Bafiertam® From Dimethyl Fumarate (PERSIST)

Relapsing Remitting Multiple Sclerosis
NCT02661555

Completed

Aerobic Exercise and Brain Health in Multiple Sclerosis

Multiple Sclerosis | Cognitive Impairment | Brain Atrophy
NCT01801982

Completed

A Non-Interventional Follow Up Study For Subjects Who Received Sildenafil for Persistent Pulmonary Hypertension of the Newborn (PPHN)

Pulmonary Hypertension, Persistent, of the Newborn
NCT03093324

Completed

A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2

Relapsing Remitting Multiple Sclerosis
NCT00745615

Terminated

An Extension Study of LAQ/5062 Exploring the Long Term Safety, Tolerability and Clinical Effect Parameters During the Disease

Relapsing Remitting Multiple Sclerosis
NCT01395316

Completed

Alemtuzumab on Surrogate Markers of Disease Activity and Repair Using Advanced MRI Measures in Subjects With Relapsing Remitting Multiple Sclerosis

Multiple Sclerosis
NCT01791894

Completed

Arsenic Trioxide in Treating Patients With Basal Cell Carcinoma (ATO)

Recurrent Skin Cancer | Basal Cell Carcinoma of the Skin
NCT01185821

Completed

Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis

Relapsing Remitting Multiple Sclerosis
NCT00616187

Completed

Atorvastatin in Relapsing-Remitting Multiple Sclerosis

Relapsing Remitting Multiple Sclerosis
NCT01384825

Completed

Observational Study of the Prevalence of CCSVI in Multiple Sclerosis and in Other Neurodegenerative Diseases (COSMO)

Multiple Sclerosis | Neurodegenerative Diseases
NCT02647502

Completed

A Pilot Study of Intermittent Calorie Restriction in Multiple Sclerosis

Relapsing Remitting Multiple Sclerosis
NCT02776072

Completed

Observational Study to Characterize Real-world Clinical Outcomes With Relapsing-remitting Multiple Sclerosis (RRMS) (EFFECT)

Multiple Sclerosis
NCT00575653

Completed

Safety Study of GBS Following Menactra Meningococcal Vaccination

Guillain-Barre Syndrome
NCT01433250

Completed

A Study to Evaluate the Safety, Tolerability and Efficacy of AIN457 in Patients With Relapsing-remitting Multiple Sclerosis

Multiple Sclerosis
NCT02696590

Completed

High Dose Oral Versus Intramuscular Vitamin D3 Supplementation In Multiple Sclerosis Patients

Relapsing Remitting Multiple Sclerosis
NCT02472938

Withdrawn

Study to Explore the Onset of Efficacy on Magnetic Resonance Disease Activity of BG00012 (Dimethyl Fumarate) in Patients With Relapsing remitTing Multiple Sclerosis (PROMPT)

Relapsing Remitting Multiple Sclerosis
NCT01945359

Completed

Pilot Study to Assess Disease Stability in a Natalizumab to Dimethyl Fumarate Crossover Design (IIT6)

Relapsing Remitting Multiple Sclerosis
NCT01497262

Completed

Safety and Tolerability of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis

Multiple Sclerosis
NCT01097668

Completed

ATX-MS-1467 in Patients With Relapsing Forms of Multiple Sclerosis

Relapsing Remitting Multiple Sclerosis
NCT01354665

Completed

Depression and Fatigue in MS Patients Treated With Betaferon. (FADO)

Multiple Sclerosis
NCT01349270

Completed

Randomized Open-label Trial to Compare Efficacy and Tolerance of Corticosteroids and IVIg (PRNC)

Demyelinating Polyneuropathy
NCT01704183

Completed

Effect of Fingolimod on the Cardiac Autonomic Regulation in Patients With Multiple Sclerosis (FingoHRV)

Relapse-remitting Multiple Sclerosis
NCT01428726

Completed

A Phase IIa Study of NT-KO-003 for Multiple Sclerosis

Relapsing Remitting Multiple Sclerosis
NCT01225289

Completed

Impact of Vitamin A Supplementation on Immune System in Multiple Sclerosis Patients

Relapsing Remitting Multiple Sclerosis
NCT00429442

Withdrawn

Simvastatin as an add-on Treatment to Copaxone for the Treatment of Relapsing Multiple Sclerosis

Relapsing Remitting Multiple Sclerosis
NCT01110993

Completed

An Observational Study to Evaluate Quality of Life (QoL) and Influence of Cognitive Status on QoL in Patients With Relapsing-Remitting Multiple Sclerosis (RRMS) During 2 Years Treatment With Rebif New Formulation (RNF) (MusiClock)

Multiple Sclerosis, Relapsing-Remitting
NCT00292253

Completed

Tolerability of Rebif® Injection With and Without the Use of Rebiject™Mini in Relapsing-Remitting Multiple Sclerosis Subjects

Multiple Sclerosis, Relapsing-remitting
NCT01407211

Unknown

Impact of Vitamin A on Gene Expression, in Multiple Sclerosis Patient (MS)

Relapsing Remitting Multiple Sclerosis
NCT00662649

Completed

Long-term Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis

Multiple Sclerosis
NCT00395317

Completed

Study Of SB-683699 Compared To Placebo In Subjects With Relapsing-Remitting Multiple Sclerosis (MS)

Multiple Sclerosis
NCT00937677

Completed

Effect of Tysabri in Patients With Relapsing-Remitting Multiple Sclerosis: A Follow-up Magnetization Transfer Imaging (MTI) Study

Multiple Sclerosis
NCT01371071

Unknown

Cohort Study of Clinically Isolated Syndrome and Early Multiple Sclerosis (CIS-COHORT)

Multiple Sclerosis, MS | Clinically Isolated Syndrome
NCT00203073

Completed

A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis.

Relapsing Remitting Multiple Sclerosis
NCT00349193

Completed

A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod

Relapsing Remitting Multiple Sclerosis
NCT00035529

Terminated

A Study to Evaluate the Preliminary Efficacy Pharmacokinetics and Immunogenicity of BMS-188667 Administered to Subjects With Relapsing-remitting Multiple Sclerosis

Multiple Sclerosis

Clinical Trials on Borderline Resectable Adenocarcinoma of the Head of the Pancrease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations